Status:
COMPLETED
Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
Lead Sponsor:
Almirall, S.A.
Conditions:
Nail Psoriasis
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The aim of this study is to determine the efficacy and safety of topical application of the gel compared to placebo in nail psoriasis.
Eligibility Criteria
Inclusion
- Key inclusion criteria:
- Mild to moderate nail psoriasis on at least one fingernail
Exclusion
- Key exclusion criteria:
- any other skin condition, with a potential to affect the nails or to interfere with evaluation of the disease;
- history of hypersensitivity to retinoids or to other components of the trial medication
- topical treatment of nails with antipsoriatics in the 4 weeks preceding the treatment phase;
- systemic treatment of psoriasis within the three months before the treatment phase of the trial or during the trial
- intralesional steroid injection before the treatment phase of the trial
- phototherapy before the treatment phase of the trial;
- any chronic infection or condition capable of interfering with the conduct of the trial;
- evidence of drug or alcohol abuse;
- symptoms of a clinically significant illness that may influence the outcome of the trial in the four weeks preceding the treatment phase of the trial;
- participation in another clinical trial within the last 4 weeks prior to first treatment in this clinical trial;
- pregnancy or nursing;
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT02235480
Start Date
February 1 2014
End Date
May 1 2015
Last Update
June 10 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational site 3
Berlin, Germany
2
Investigational site 4
Berlin, Germany
3
Investigational 2
Hamburg, Germany
4
Investigational site 1
Hamburg, Germany